Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0 GBP
79.35 M GBP
659.83 M GBP
501.45 M
About HUTCHMED (CHINA) LIMITED
Sector
CEO
Wei Guo Su
Headquarters
Hong Kong
Website
Founded
2000
FIGI
BBG000P4SQF9
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
HCM Learning experiencePlaying Trading Simulator:
Big time rookie mistake.
Bought 350 shares at $41.71 on 3JAN18. Price was falling.
Same day bought 500 shares at $39.93 in order to dilute my buying price.
I began studying the chart and saw my mistake.
On 5JAN18 I sold my shares using a trailing stop of 10 cents.
It exe
Tracking HCMI've been a long term holder of HCM since 2009. They are also listed on the FTSE AIM 100 LSE:HCM.
They have outperformed the NASDAQ BIOTECHNOLOGY INDEX INDEX:NBI
Now would be a good place to exit.
I will continue to hold for now, i am not trading this. It's included in my long term portfolio.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HCM is 232 GBX — it hasn't changed in the past 24 hours. Watch HUTCHMED (CHINA) LIMITED ORD USD0.1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HUTCHMED (CHINA) LIMITED ORD USD0.1 stocks are traded under the ticker HCM.
HCM stock hasn't changed in a week, the month change is a −14.39% fall, over the last year HUTCHMED (CHINA) LIMITED ORD USD0.1 has showed a −18.74% decrease.
We've gathered analysts' opinions on HUTCHMED (CHINA) LIMITED ORD USD0.1 future price: according to them, HCM price has a max estimate of 642.75 GBX and a min estimate of 362.36 GBX. Watch HCM chart and read a more detailed HUTCHMED (CHINA) LIMITED ORD USD0.1 stock forecast: see what analysts think of HUTCHMED (CHINA) LIMITED ORD USD0.1 and suggest that you do with its stocks.
HCM stock is 2.64% volatile and has beta coefficient of 1.08. Track HUTCHMED (CHINA) LIMITED ORD USD0.1 stock price on the chart and check out the list of the most volatile stocks — is HUTCHMED (CHINA) LIMITED ORD USD0.1 there?
Today HUTCHMED (CHINA) LIMITED ORD USD0.1 has the market capitalization of 1.99 B, it has decreased by −2.64% over the last week.
Yes, you can track HUTCHMED (CHINA) LIMITED ORD USD0.1 financials in yearly and quarterly reports right on TradingView.
HUTCHMED (CHINA) LIMITED ORD USD0.1 is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
HCM earnings for the last half-year are 0.02 GBX per share, whereas the estimation was −0.06 GBX, resulting in a 138.22% surprise. The estimated earnings for the next half-year are −0.01 GBX per share. See more details about HUTCHMED (CHINA) LIMITED ORD USD0.1 earnings.
HUTCHMED (CHINA) LIMITED ORD USD0.1 revenue for the last half-year amounts to 241.79 M GBX, despite the estimated figure of 252.59 M GBX. In the next half-year revenue is expected to reach 305.31 M GBX.
HCM net income for the last half-year is 20.43 M GBP, while the previous report showed −53.30 M GBP of net income which accounts for 138.33% change. Track more HUTCHMED (CHINA) LIMITED ORD USD0.1 financial stats to get the full picture.
No, HCM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 1.99 K employees. See our rating of the largest employees — is HUTCHMED (CHINA) LIMITED ORD USD0.1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUTCHMED (CHINA) LIMITED ORD USD0.1 EBITDA is −87.22 M GBP, and current EBITDA margin is 3.05%. See more stats in HUTCHMED (CHINA) LIMITED ORD USD0.1 financial statements.
Like other stocks, HCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUTCHMED (CHINA) LIMITED ORD USD0.1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUTCHMED (CHINA) LIMITED ORD USD0.1 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUTCHMED (CHINA) LIMITED ORD USD0.1 stock shows the sell signal. See more of HUTCHMED (CHINA) LIMITED ORD USD0.1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.